脱水剂与阿糖腺苷联合治疗小儿病毒性脑炎的疗效分析
2016-02-06张海燕
张海燕
脱水剂与阿糖腺苷联合治疗小儿病毒性脑炎的疗效分析
张海燕
目的 探讨脱水剂与阿糖腺苷联合治疗小儿病毒性脑炎的疗效。方法 选取我院收治的72例病毒性脑炎患儿,分为对照组和研究组,每组36例,对照组患者采用单磷酸阿糖腺苷治疗,研究组在对照组的基础上联合给予脱水剂甘露醇治疗,对比两组患者的临床治疗效果。结果 研究组治疗总有效率为91.67%,对照组治疗总有效率为77.78%,两组比较差异有统计学意义(P<0.05),治疗后研究组患者的退热时间、意识恢复时间、惊厥控制时间以及头痛呕吐消失时间少于对照组(P<0.05)。结论 脱水剂与阿糖腺苷联合治疗小儿病毒性脑炎能有效的改善患儿的临床症状,疗效显著。
脱水剂;阿糖腺苷;病毒性脑炎;甘露醇;不良反应
【Abstract】
Objective To investigate the clinical effect of dehydration combined with vidarabine monophosphate in children with viral encephalitis. Methods 72 cases children with viral encephalitis in our hospital were divided into observation group(n=36) and control group(n=36) according to the therapeutic methods. Children in the control group were treated with vidarabine monophosphate, and children in the observation group were treated with dehydration combined with vidarabine monophosphate. The clinical effect were compared between the two groups. Results The clinical efficacyrate of the observation group(91.67%) was significantly higher than that of the control group(77.78%)(P<0.05). After treatment, the antifebrile time, consciousness recovery time, convulsions control time and headaches, vomiting disappear time of the observation group were significantly less than those of the control group(P<0.05). Conclusion Dehydration combined with vidarabine monophosphate in children with viral encephalitis could effectively improve the children's clinical symptoms and has remarkable clinical effect.
【Key words】Dehydrating agent, Vidarabine, Viral encephalitis, Mannitol, Adverse reactions
小儿病毒性脑炎是由病毒引起的中枢神经系统感染性疾病,多由肠道病毒、虫媒病毒、常见传染病病毒以及单纯疱疹病毒所致,好发于夏季,临床常见症状为发热、头痛、呕吐、嗜睡、昏迷、惊厥等,若未得到及时有效的治疗,将可能导致后遗症及死亡[1-2]。临床上常采用降低颅内压、保护脑细胞、纠正水电解质及酸碱平衡、营养支持等对症治疗,但效果难以达到临床预期[3]。本研究旨在探讨脱水剂与阿糖腺苷联合治疗小儿病毒性脑炎的疗效,现报告如下。
1 资料与方法
1.1 一般资料
选取我院2013年3月~2016年3月收治的72例病毒性脑炎患儿,所有患儿经头颅CT及脑脊液检查均符合病毒性脑炎的诊断标准,家长知情同意签署知情同意书。……
